A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes.
Human African Trypanosomiasis is a vector-borne disease of sub-Saharan Africa that causes significant morbidity and mortality. Current therapies have many drawbacks, and there is an urgent need for new, better medicines. Ideally such new treatments should be fast-acting cidal agents that cure the di...
Saved in:
| Main Authors: | Manu De Rycker, Sandra O'Neill, Dhananjay Joshi, Lorna Campbell, David W Gray, Alan H Fairlamb |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001932&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.
by: Lorna M MacLean, et al.
Published: (2018-07-01) -
Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi
by: Nathan Habila, et al.
Published: (2010-01-01) -
Modelling motility of Trypanosoma brucei.
by: Florian A Overberg, et al.
Published: (2025-05-01) -
CHARACTERIZATION AND ANTIPARASITIC ACTIVITY OF BENZOPHENONE THIOSEMICARBAZONES ON Trypanosoma brucei brucei
by: Georges C. Accrombessi, et al.
Published: (2011-02-01) -
Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei.
by: Sam Alsford, et al.
Published: (2014-05-01)